Submitted by Anonymous (not verified) on 15 October 2026 - 9:36
Human medicines European public assessment report (EPAR): Opuviz, aflibercept, Date of authorisation: 13/11/2024, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Opuviz, aflibercept, Date of authorisation: 13/11/2024, Revision: 5, Status: Authorised